Načítá se...

Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma

PURPOSE: Activation of the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase/AKT pathway seems to be critical for melanoma proliferation. Components of these pathways are client proteins of heat-shock protein 90 (hsp90), suggesting that inhibition of hsp90 could h...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Solit, David B., Osman, Iman, Polsky, David, Panageas, Katherine S., Daud, Adil, Goydos, James S., Teitcher, Jerrold, Wolchok, Jedd D., Germino, F. Joseph, Krown, Susan E., Coit, Daniel, Rosen, Neal, Chapman, Paul B.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2629404/
https://ncbi.nlm.nih.gov/pubmed/19088048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-1002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!